Italia markets close in 6 hours 14 minutes

Johnson & Johnson (JNJ)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
151,24-0,03 (-0,02%)
Alla chiusura: 04:00PM EDT
151,21 -0,03 (-0,02%)
Preborsa: 04:50AM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente151,27
Aperto151,78
Denaro0,00 x 1000
Domanda151,40 x 800
Min-Max giorno150,79 - 152,59
Intervallo di 52 settimane143,13 - 175,97
Volume5.482.489
Media Volume7.385.509
Capitalizzazione363,986B
Beta (mensile su 5 anni)0,55
Rapporto PE (ttm)22,47
EPS (ttm)6,73
Prossima data utili17 lug 2024
Rendimento e dividendo (futuro)4,96 (3,28%)
Data ex dividendo20 mag 2024
Stima target 1A172,72
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA